In Vitro Modeling of the HIV-macrophage Reservoir
Overview
Affiliations
Macrophages are recognized as a putative reservoir for HIV-1, but whether HIV can establish latent infection in this cell type is not known. An in vitro model using long-term cultured primary human monocyte-derived macrophages (MDM) infected with an M-tropic, enhanced green fluorescent protein (EGFP) tagged reporter virus was developed to test the hypothesis that HIV can establish a latent infection of this cell type. The EGFP-IRES-Nef cassette allowed detection of early gene transcription. The expression of GFP+ MDM was followed with time and the GFP- population was purified and analyzed for evidence of latent infection. Interestingly, in MDM cultures propagated for over two months, distinct subpopulations of infected GFP+ cells were observed and quantitated. In particular, infected MDM that displayed a high level of transcription, characterized as the GFP hi group, yet produced low levels of the late viral gene product, p24, increased with time and represented 10% of the GFP+ population in long-term cultures. The high level production of early genes such as Nef, a protein that can facilitate viral immune escape, but low level of structural proteins such as p24 in the GFP hi population suggests that a subset of infected MDM can exhibit an alternative mode of replication. The GFP- MDM population obtained by a two-step purification protocol using flow cytometry and laser ablation contained integrated provirus as assessed by Alu-LTR real-time PCR analyses. A subset of these, were replication competent as shown by their ability to express GFP and/or p24 antigen after reactivation with IL-4.
Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells.
Howard J, Levinger C, Deletsu S, Fromentin R, Chomont N, Bosque A PLoS Pathog. 2024; 20(10):e1012601.
PMID: 39401241 PMC: 11501018. DOI: 10.1371/journal.ppat.1012601.
Three-stage modeling of HIV infection and implications for antiretroviral therapy.
Clarke C, Pankavich S J Math Biol. 2024; 88(3):34.
PMID: 38418658 DOI: 10.1007/s00285-024-02056-1.
Kim S, Filsinger Interrante M, Kim P J Virol. 2022; 97(1):e0164722.
PMID: 36541800 PMC: 9888200. DOI: 10.1128/jvi.01647-22.
Chen J, Zhou T, Zhang Y, Luo S, Chen H, Chen D Front Cell Infect Microbiol. 2022; 12:945956.
PMID: 35967854 PMC: 9368196. DOI: 10.3389/fcimb.2022.945956.
HIV Latency in Myeloid Cells: Challenges for a Cure.
Chitrakar A, Sanz M, Maggirwar S, Soriano-Sarabia N Pathogens. 2022; 11(6).
PMID: 35745465 PMC: 9230125. DOI: 10.3390/pathogens11060611.